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We demonstrated previously that ET-1 and cAMP may syner-
gistically induce IL-6 release from adipocytes, mainly through
their strong stimulatory effect on IL-6 gene expression. In the
present study, we further examined the signaling pathways that
may be involved. A luciferase reporter driven by promoter
(−1310/+198) of mouse IL-6 gene was transfected into 3T3-L1
adipocytes to monitor IL-6 transcription in response to ET-1 and
8-bromo cAMP, and the effects of various inhibitory agents were
tested. Whereas the stimulatory effect of ET-1 alone was inhibited
by pertussis toxin (PT), GF109203X, U0126, N-acetylcysteine,
salicylate, dominant negative CREB (dn- CREB) and mithramycin
A, the stimulatory effect of 8-bromo cAMP was only inhibited by
dn-CREB. On the other hand, the synergistic effect of ET-1 and
cAMP was suppressed by GF109203X, U0126, salicylate, c-Jun-
speciﬁc antisense oligonucleotide (AS-cJun) and dn-CREB. PT had
a partial inhibitory effect, while NAC and mithramycin A had no
inﬂuence. Since NF-kB activation by ET-1 is mediated by a
PKC&epsilon/ROS cascade, the observation that the synergistic
effect of ET-1 and cAMP was inhibited by salicylate but not NAC
suggests salicylate inhibited some factor in addition to NF-kB. Indeed,
we found that another salicylate target p90 ribosomal S6 Kinase (RSK)
was involved. Taken together, the synergistic effect of ET-1 and cAMP
on IL-6 gene transcription seems to bemediated by pathways involving
PKC, MAPK, CREB, AP-1 and RSK.
doi:10.1016/j.lfs.2013.12.126
A novel mouse model to characterize the mechanisms of
endothelin-1-induced vascular injury
Pierre Paradisa, Suellen C. Coelhoa,
Yohann Rautureaua, Ernesto L. Schiffrina,b
aLady Davis Institute for Medical Research, McGill University,
Montreal PQ, Canada
bDepartment of Medicine, Sir Mortimer B. Davis-Jewish General Hospital,
McGill University, Montreal PQ, Canada
E-mail address: pierre.paradis@mcgill.ca (P. Paradis)
Background: To develop a model to study of the mechanisms of
endothelin-1 (ET-1)-induced vascular injury, we generated an
inducible endothelial cell (EC)-restricted human ET-1 (EDN1) cDNA
overexpressing transgenic mouse. Methods and results: A transgene
was engineered that expresses chloramphenicol acetyltransferase (cat)
and EDN1 cDNA prior and after Cre-mediated excision, respectively,
under the control of cytomegalovirus immediate early enhancer/
chicken β-actin promoter (CAG). Co-transfection of Cre expression
vector and pCAG-cat-EDN1 caused 30-fold increase in ET-1 production.
Transgenic mice were generated and two of seven founder lines were
selected based on their cardiac cat expression level, which was twice
higher in line C-134 than C-170. Inducible EC-restricted EDN1 mice
were generated crossing CAG-cat-EDN1 mice with transgenic mice
expressing CreERT2 under control of EC-speciﬁc Tie2 promoter. To
investigate the extent of CreERT2 activation by tamoxifen and tissue
speciﬁcity, Tie2-CreERT2micewere crossedwith ROSAmT-mG/mT-mG
reporter mice expressing a membrane-targeted tandem dimer tomato
(mT) before Cre-mediated excision, and membrane-targeted enhanced
green ﬂuorescent protein (mG) after excision. Tie2-CreERT2/cat-EDN1
and Tie2-CreERT2/ROSAmT-mG/+ mice were treated subcutaneously
with 1 mg tamoxifen/day for 5 days and sacriﬁced 14–16 days later. mG
expression was detected in 22 ± 3% of mesenteric artery ECs of Tie2-
CreERT2/ROSAmT-mG/+ mice. Plasma ET-1 levels were similar in
vehicle-treated Tie2-CreERT2/cat-EDN1 (1.2 ± 0.1 pg/mL, n = 4) and
wild-type mice (1.1 ± 0.1 pg/mL, n = 2), demonstrating no leaky
expression. Tamoxifen induced 8-fold increase in plasma ET-1 levels
in Tie2-CreERT2/cat-EDN1 mice (9.1 ± 0.3 pg/mL, n = 4). Conclusion:
Tie2-CreERT2/cat-EDN1-inducible EC-restricted EDN1 overexpressing
mice allow the study of ET-1 vascular effects independently of
developmental effects.
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In human atherosclerosis, which is associated with elevated
plasma and coronary endothelin (ET)-1 levels, ETA receptor
antagonists improved coronary endothelial function. Mice overex-
pressing ET-1 speciﬁcally in the endothelium (eET-1) crossed with
apolipoprotein E knockout mice (Apoe−/−) exhibited exaggerated
high-fat diet (HFD)-induced atherosclerosis. Since endothelial
dysfunction often precedes atherosclerosis development, we inves-
tigated whether endothelium-speciﬁc ET-1 overexpression causes
endothelial dysfunction in Apoe−/− mice. Male 8-week old eET-1,
Apoe−/−, eET-1/Apoe−/− and wild-type mice were fed a regular
diet or HFD for 8 weeks. Endothelial function was assessed in
mesenteric arteries by pressurized myography. In HFD-fed mice,
acetylcholine-induced endothelium-dependent relaxation (EDR) was
reduced 67% in Apoe−/− and 41% in eET-1 compared to wild-type
(P b 0.05). Surprisingly, EDR was not impaired in eET-1/Apoe−/−
compared to wild-type. Endothelium-independent relaxation to
nitric oxide donor sodium nitroprusside and contractile responses
to norepinephrine were unaffected. Similar results were observed in
regular diet-fed mice. In the presence of inhibitors of either nitric
oxide synthase (NOS)-mediated relaxation, Nω-nitro-l-arginine methyl
ester, or endothelium-dependent hyperpolarization (EDH)-mediated
relaxation, apamin plus Tram34, EDR was blunted in wild-type
(P b 0.01), whereas NOS-mediated relaxation was reduced 22% (P b
0.05) and EDH-mediated relaxation unaffected in eET-1/Apoe−/−.
However, the concomitant inhibition of NOS- and EDH-mediated
relaxation reduced EDR 51% in eET-1/Apoe−/− (P b 0.05). These results
showan interdependence of NOS and EDHpathways in EDR inwild-type
mice. ET-1 overexpression induced development of compensatory
mechanisms in pre-atherosclerotic arteries of Apoe−/− mice, which
permits either NOS or EDH pathway to mediate EDR independently.
Investigation of mechanisms involved in EDR remodeling in eET-1/
Apoe−/− mice will allow a better understanding of the ET-1 role in
atherosclerosis.
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